INVO Fertility, Inc IVF

0.94 0.00 0.00% as of 25 Sep
Market cap
$4.4M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
883,505,236.93 69,243,011.43 115,368,949.17 26.92 16.71 9.22 6.15 0.61 0.54 0.06
P/FCF ratio
0.00 0.00 0.00 30.52 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(455,655,492.75) (1,001,715,565.31) (199,116,171.69) (51.68) (9.52) (25.39) (5.04) (2.58) (5.67) 17.50
P/B ratio
0.00 0.00 0.00 0.00 3.02 5.25 0.00 0.00 0.00 0.09
Price to Tangible BV
0.00 0.00 0.00 0.00 3.07 5.34 0.00 0.00 0.00 0.00
EV/Sales
883,505,236.72 69,243,011.84 115,368,949.44 26.34 7.55 8.37 9.28 1.64 1.41 (0.11)
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.14
EV/Operating CF
(138,567,662.94) (107,741,057.03) (87,330,584.54) 28.45 (1.64) (5.77) (1.16) (1.04) (3.09) 0.11
EV/FCF
(138,567,662.94) (107,741,057.03) (87,330,584.54) 29.86 (1.61) (5.34) (1.15) (0.95) (2.98) 0.11
Quick Ratio
0.03 0.02 0.13 0.83 4.42 4.58 0.05 0.05 0.04 0.22
Current Ratio
0.05 0.05 0.21 1.03 4.61 5.03 0.19 0.16 0.07 0.27
Net Debt/EBITDA
0.01 (0.50) 0.02 0.61 3.18 0.92 (0.25) (0.17) (0.10) 0.25
Debt/Assets
49.51% 128.60% 20.20% 20.94% 5.43% 20.29% 71.82% 6.78% 2.45% 3.68%
Debt/Equity
(0.03) (0.07) (0.06) (0.10) 0.10 0.29 (2.73) 1.40 0.09 0.10
Asset Turnover
0.12 1.02 0.95 1.15 0.16 0.39 0.12 0.27 0.20 0.21
Operating CF/Net income
0.15 0.26 0.21 (0.63) 0.57 0.91 0.61 0.59 0.31 0.28
Capex/Depreciation
(8.26) 0.00 (0.05) (0.32) (0.04) (0.34) (0.10) (0.48) (0.07) (0.02)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
50.73% 14.61% 79.73% 67.34% (822.60%) (101.96%) (343.99%) 264.08% 83.06% 387.43%
ROA
(490.60%) (254.14%) (589.46%) (168.49%) (131.01%) (62.16%) (153.67%) (72.33%) (29.45%) (75.81%)
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% (86.96%) (416.01%) (220.95%) (31.64%) (76.78%)
Return on Tangible Assets
47.15% 14.40% 112.43% (1,600.81%) (99.53%) (119.82%) 477.70% 135.80% 58.90% 349.81%
Average Days of Receivables
20.08 112.18 166.77 1.87 7.64 4.43 34.23 16.99 6.32 11.59
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 38.41% 5.20% 66.16% 5.49% 0.08% 0.00%
Selling, General and Administrative Expense of Revenue
4,216.50% 308.61% 614.50% 211.36% 584.70% 216.71% 1,213.40% 247.85% 123.48% 112.42%
Intangible Assets out of Total Assets
0.07 0.06 0.02 0.03 0.01 0.01 0.00 0.54 0.20 0.36
Share Based Compensation of Revenue
2,482.51% 76.25% 423.28% 4.31% 59.38% 27.99% 73.95% 11.40% 19.09% 18.86%
Graham Net Nets
0.00 0.00 0.00 (0.10) 0.31 0.08 (0.80) (8.87) (9.21) (23.20)
Graham Number
0.11 0.06 0.09 48,563.72 0.00 0.00 37,763.13 30,214.18 21,583.50 1,220.36
Earnings Yield
0.00% 0.00% 0.00% (2.83%) (50.71%) (18.83%) (205.11%) (430.99%) (299.32%) 42,636.66%
Free Cash Flow Yield
0.00% 0.00% 0.00% 3.28% (28.06%) (16.98%) (130.82%) (282.20%) (88.15%) (1,600.54%)
Revenue per Share
0.00 0.00 0.00 7,401.00 5,186.50 10,400.25 2,055.50 3,020.60 2,177.33 58.47
Operating CF per Share
0.00 0.00 0.00 6,852.50 (23,875.50) (15,074.75) (16,508.25) (4,755.10) (991.47) (59.95)
Capex per Share
0.00 0.00 0.00 (573.50) (445.00) (1,136.50) (31.75) (444.70) (36.03) (0.37)
Free Cash Flow per Share
0.00 0.00 0.00 6,279.00 (24,320.50) (16,211.25) (16,540.00) (5,199.80) (1,027.50) (60.32)
Cash per Share
0.00 0.00 0.00 6,193.00 50,489.00 14,212.25 225.25 232.40 206.50 17.76
Shareholders Equity per Share
(0.03) (0.04) (0.02) (18,568.00) 28,715.50 18,276.75 (2,444.00) 892.60 4,194.80 61.75
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.00
Book value per Share
(0.03) (0.04) (0.02) (18,568.00) 28,715.50 18,276.75 (2,444.00) 892.60 4,194.80 61.75
Free Cash Flow
(0.34) (0.18) (0.67) 1.26 (4.86) (6.48) (6.62) (5.20) (3.08) (7.06)
Working Capital
(4.52) (4.89) (2.77) 0.04 8.25 5.05 (2.72) (6.74) (16.61) (7.57)
Capital Expenditures
(0.02) — (0.02) (0.11) (0.09) (0.45) (0.01) (0.44) (0.11) (0.04)
Net Current Asset Value
(4.65) (5.02) (2.77) (3.97) 5.34 3.15 (4.07) (16.35) (32.24) (10.23)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10
Capex to Sales
0.31 0.00 0.04 0.08 0.09 0.11 0.02 0.15 0.02 0.01
Net Profit Margin
(4,173.48%) (248.92%) (622.19%) (146.43%) (804.71%) (159.97%) (1,324.80%) (265.99%) (145.58%) (367.33%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.12 0.18 10.79 3.90 19.13 2.70 0.30 1.11 3.30 4.82
Cash ROIC
7.85% 4.26% 29.19% (60.86%) (29.86%) (43.20%) (396.24%) (234.62%) (24.01%) (73.66%)
Accounts Receivable Turnover
24.83 6.30 3.16 12.68 70.81 115.24 12.89 27.75 51.49 41.41
Accounts Payable Turnover
0.02 0.05 0.12 0.28 0.25 0.38 0.95 1.05 1.34 1.68
Inventory Turnover
0.20 0.72 1.77 1.85 0.48 0.52 3.09 7.33 15.11 19.38
Average Days of Payables
23,565.46 6,743.38 2,308.71 1,014.19 1,351.90 1,115.38 578.73 439.72 310.71 172.15
Days of Inventory on Hand
2,059.47 413.43 175.64 276.82 1,090.89 723.96 113.09 49.91 21.93 19.07
Average Receivables
0.00 0.04 0.16 0.12 0.01 0.04 0.06 0.11 0.13 0.17
Average Payables
1.00 0.97 0.77 0.47 0.35 0.39 0.90 1.84 2.72 2.57
Average Inventory
0.08 0.07 0.05 0.07 0.18 0.28 0.28 0.26 0.24 0.22
Average Assets
0.43 0.28 0.52 1.29 6.37 10.71 7.09 11.11 32.29 33.15
Average Common Equity
(4.19) (4.80) (3.86) (3.22) 1.01 6.53 3.17 (3.04) (11.45) (6.49)

Fold the line items

Columns are period end dates